SEC Form D · Amendment · filed September 21, 2022
Triumvira Immunologics Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (33)
Paul K. Berns · Madison, WIDirectorJames S. Corl · New York, NYDirectorGregory R. Piefer · JANESVILLE, WIDirectorDanting Wang · Grand Cayman, Cayman IslandsExecBrandon Arvanaghi · Miami Beach, FLDirectorBrian M. Bloom · AUSTIN, TXDirectorCynthia M. Collins, Mba · AUSTIN, TXDirectorLee M. Cooper · AUSTIN, TXDirectorDavid A. Newberg · JANESVILLE, WIExec · DirectorVernon D. Gair Jr · Chicago, ILDirectorJacob Bond · Vancouver, WADirectorScott M. Smith · AUSTIN, TXDirectorSteven K. Galson · Madison, WIExec · DirectorManeesh K. Arora · Madison, WIDirectorDennis Tilley · Seattle, WADirectorYiran Liu · Grand Cayman, Cayman IslandsExecKennedy Lewis Investments Holdings II LLC · New York, NYDirectorRobert F. Bierig · Chicago, ILExecAndrew Cunningham · Washington, Washington, D.C.ExecDanting Wang · Grand Cayman, Cayman IslandsDirectorAndrea K. Jackson · Madison, WIDirectorPaul Lammers, Md, Msc · AUSTIN, TXExec · DirectorEric G. Schutt · JANESVILLE, WIDirectorDavid Linton · Snohomish, WADirectorJurgen M. Eckhardt · AUSTIN, TXDirectorJeremy Burger · Seattle, WADirectorWidya M. Mulyasasmita · AUSTIN, TXDirectorTeresa C. Mcroberts · AUSTIN, TXExecElizabeth C. Williams · AUSTIN, TXDirectorDaniel C. Janse · AUSTIN, TXDirectorJon C. Irvin · AUSTIN, TXExecAdam Castelbaum · PHILADELPHIA, PADirectorGregory D. Smith · JANESVILLE, WIDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗